Gene Therapy Stalls Development Of Huntington's Disease In Mice
Sunday, November 8, 2009 - 22:28
in Biology & Nature
Researchers at the California Institute of Technology have shown that a highly specific intrabody (an antibody fragment that works against a target inside a cell) is capable of stalling the development of Huntington's disease in a variety of mouse models. "Gene therapy in these models successfully attenuated the symptoms of Huntington's disease and increased life span," notes Paul Patterson, the Anne P. and Benjamin F. Biaggini Professor of Biological Sciences.
Read the whole article on Science Daily
More from Science Daily
Related
- Caltech researchers show efficacy of gene therapy in mouse models of Huntington's diseaseFri, 30 Oct 2009, 13:22:38 EDT
- 'Intrabody' can mop up mutant protein in Huntington's disease modelMon, 26 May 2008, 3:49:17 EDT
- Researchers find potential treatment for Huntington's diseaseSun, 15 Nov 2009, 13:49:31 EST
- Researchers develop first transgenic monkey model of Huntington's diseaseSun, 18 May 2008, 13:35:27 EDT
- Huntington's disease decipheredSun, 14 Jun 2009, 13:44:02 EDT